CPRT vs TRI

Copart (CPRT) presents a compelling investment opportunity despite near-term price weakness, with strong profitability, robust earnings growth, and a favorable valuation relative to high-quality peers. The company's 33.4% profit margin and 36.7% operating margin are exceptional in the Industrials sector, significantly outpacing sector averages. While 1-year returns are deeply negative (-28.4%), the stock trades below a $53.33 analyst target, implying ~30% upside, and exhibits accelerating earnings growth (24.2% YoY) amid disciplined capital structure. Notably, insider selling introduces caution, but strong fundamentals and sector-relative resilience support a bullish stance.

TRI presents a stark contrast between operational health and valuation; while the Piotroski F-Score of 7/9 indicates strong internal financial health, the stock is trading at a massive premium to its Graham Number ($44.31) and Intrinsic Value ($23.03). A severe contraction in earnings growth (-42.6% YoY) and a high PEG ratio of 6.25 suggest the current price is not supported by current fundamentals. However, the company maintains a very conservative debt profile (Debt/Equity 0.20) and continues to receive bullish analyst support. The overall outlook is neutral as the operational strength provides a floor, but the valuation gap and earnings decline create significant headwinds.